Core Insights - Three stocks with strong momentum and buy rankings are highlighted for investors: HudBay Minerals, Byrna Technologies, and Jackson Financial [1][2][3][4] Group 1: HudBay Minerals - HudBay Minerals is engaged in the discovery, production, and marketing of base metals in North and Central America [1] - The company has a Zacks Rank of 1 (Strong Buy) and a 5% increase in the Zacks Consensus Estimate for current year earnings over the last 60 days [1] - HudBay's shares gained 67.9% over the last three months, significantly outperforming the S&P 500's gain of 6.1% [2] - The company possesses a Momentum Score of A [2] Group 2: Byrna Technologies - Byrna Technologies develops and manufactures innovative non-lethal equipment and munitions [2] - The company also has a Zacks Rank of 1 and an 11.1% increase in the Zacks Consensus Estimate for current year earnings over the last 60 days [2] - Byrna's shares gained 9.2% over the last three months, again outperforming the S&P 500's gain of 6.1% [2] - The company possesses a Momentum Score of A [2] Group 3: Jackson Financial - Jackson Financial is a U.S. retirement services provider with a diverse portfolio of differentiated products [3] - The company has a Zacks Rank of 1 and a 4.8% increase in the Zacks Consensus Estimate for current year earnings over the last 60 days [3] - Jackson Financial's shares gained 9.3% over the last three months, also outperforming the S&P 500's gain of 6.1% [4] - The company possesses a Momentum Score of A [4]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," rather than traditional strategies of buying low and waiting for recovery [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point, as stocks may lose momentum when their valuations exceed future growth potential [2] - Investing in bargain stocks that exhibit recent price momentum can be a safer strategy, utilizing tools like the Zacks Momentum Style Score to identify promising stocks [3] Group 2: Par Petroleum (PARR) Analysis - Par Petroleum (PARR) has shown a four-week price change of 1.4%, indicating growing investor interest [4] - Over the past 12 weeks, PARR's stock gained 4.3%, with a beta of 1.74, suggesting it moves 74% more than the market [5] - PARR has a Momentum Score of A, indicating a favorable time to invest based on momentum [6] Group 3: Earnings Estimates and Valuation - PARR has received upward revisions in earnings estimates, earning a Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - The stock is trading at a Price-to-Sales ratio of 0.22, indicating it is relatively cheap at 22 cents for each dollar of sales [7] Group 4: Additional Investment Opportunities - Besides PARR, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - The Zacks Premium Screens offer over 45 strategies tailored to help investors find winning stock picks [9]

Core Insights - The biotechnology sector has seen notable momentum, with four stocks entering the top 10th percentile based on significant week-on-week gains [1][2] Group 1: Key Biotech Stocks - Aldeyra Therapeutics Inc. (ALDX) experienced a momentum percentile surge from 32.07 to 91.32, marking a 59.25-point increase, with an 8.62% year-to-date rise and a 6.58% increase over the year [6] - Alector Inc. (ALEC) improved its momentum percentile from 87.61 to 92.19, a 4.58-point rise, showing a 66.14% year-to-date increase but a decline of 30.99% over the year [6] - Black Diamond Therapeutics Inc. (BDTX) advanced its percentile from 88.36 to 92.61, a 4.25-point gain, with a remarkable 101.87% year-to-date increase and a 25.58% rise over the year [7] - Coherus Oncology Inc. (CHRS) edged up from 89.10 to 92.71, a climb of 3.61 percentile points, with a 30.00% year-to-date increase and an impressive 87.63% rise over the year [7] Group 2: Market Context - The S&P 500 index closed 0.28% lower, while the Nasdaq 100 and Dow Jones indices also saw declines of 0.15% and 0.52% respectively [5] - Futures for the S&P 500, Dow Jones, and Nasdaq 100 indices were trading higher on the following Friday, indicating potential market recovery [5]

Core Insights - The biotechnology sector has seen notable momentum, with four stocks entering the top 10th percentile based on significant week-on-week gains [1][2] Group 1: Key Biotech Stocks - Aldeyra Therapeutics Inc. (ALDX) experienced a momentum percentile surge from 32.07 to 91.32, marking a 59.25-point increase, with an 8.62% year-to-date rise and a 6.58% increase over the year [6] - Alector Inc. (ALEC) improved its momentum percentile from 87.61 to 92.19, a 4.58-point rise, showing a 66.14% year-to-date increase but a decline of 30.99% over the year [6] - Black Diamond Therapeutics Inc. (BDTX) advanced its percentile from 88.36 to 92.61, a 4.25-point gain, with a year-to-date increase of 101.87% and a 25.58% rise over the year [7] - Coherus Oncology Inc. (CHRS) edged up from 89.10 to 92.71, a climb of 3.61 percentile points, with a 30.00% year-to-date increase and an 87.63% rise over the year [7] Group 2: Market Context - The S&P 500 index closed 0.28% lower, while the Nasdaq 100 and Dow Jones indices also saw declines of 0.15% and 0.52% respectively, indicating a mixed market environment [5]

Core Insights - Three stocks with strong momentum and buy rankings are highlighted for investors: NETGEAR, Envela Corporation, and Steelcase Inc. [1][2][3] Company Summaries - **NETGEAR, Inc. (NTGR)**: - Zacks Rank: 1 - Earnings estimate increase: 86.7% over the last 60 days - Share price increase: 12.5% over the last three months, outperforming the S&P 500's 6.9% [1] - Momentum Score: A [1] - **Envela Corporation (ELA)**: - Zacks Rank: 1 - Earnings estimate increase: 16.7% over the last 60 days - Share price increase: 17.3% over the past three months, also outperforming the S&P 500's 6.9% [2] - Momentum Score: B [2] - **Steelcase Inc. (SCS)**: - Zacks Rank: 1 - Earnings estimate increase: 4.8% over the last 60 days - Share price increase: 53.9% over the last three months, significantly outperforming the S&P 500's 6.9% [3] - Momentum Score: B [3]

Core Insights - Zacks Premium provides tools for investors to enhance their stock market engagement and confidence, including daily updates, research reports, and stock screens [1] Zacks Style Scores - Zacks Style Scores are indicators that assist investors in selecting stocks likely to outperform the market within 30 days, rated from A to F based on value, growth, and momentum [2] - The Value Score identifies attractive stocks using ratios like P/E and Price/Sales, focusing on discounted stocks [3] - The Growth Score emphasizes a company's financial health and future outlook, analyzing projected and historical earnings and cash flow [4] - The Momentum Score helps investors capitalize on price trends, using factors like one-week price change and monthly earnings estimate changes [5] - The VGM Score combines all three Style Scores, providing a comprehensive indicator for stock selection based on value, growth, and momentum [6] Zacks Rank - The Zacks Rank is a proprietary model based on earnings estimate revisions, with 1 (Strong Buy) stocks achieving an average annual return of +23.81% since 1988, significantly outperforming the S&P 500 [7] - There are over 800 stocks rated 1 or 2, making it essential for investors to utilize Style Scores to narrow down choices [8] - To maximize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [9] - Stocks with a 4 (Sell) or 5 (Strong Sell) rating, even with high Style Scores, are less favorable due to declining earnings forecasts [10] Company Spotlight: Microsoft - Microsoft Corporation holds over 73% market share in the desktop operating system sector and is rated 2 (Buy) on the Zacks Rank with a VGM Score of B [11] - The company has a Momentum Style Score of A, with shares increasing by 4.9% in the past four weeks [11] - Recent upward revisions in earnings estimates for fiscal 2026 have raised the Zacks Consensus Estimate to $15.41 per share, with an average earnings surprise of +7% [12]

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 8th:Coeur Mining, Inc. (CDE) : This gold and silver producer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.2% over the last 60 days.Coeur Mining’s shares gained 109.8% over the last three months compared with the S&P 500’s advance of 7.6%. The company possesses a Momentum Score  of A.LanzaTech Global, Inc. (LNZA) : This carbon refining ...

Core Viewpoint - Oracle (ORCL) stock is positioned as a strong investment opportunity due to its robust margins, low-debt capital structure, fair valuation, and positive momentum [2] Financial Performance - Oracle experienced a revenue growth of 9.7% over the last twelve months (LTM) and an average growth of 10.2% over the past three years [7] - The company has an operating cash flow margin of approximately 35.6% and an average operating margin of 30.3% over the last three years [7] Market Position - Oracle is currently in the top 10 percentile of stocks based on "trend strength," indicating strong momentum [7] - Despite its positive momentum, ORCL stock is trading 13% lower than its 52-week peak, suggesting potential for further growth [7] Investment Strategy - The selection strategy for stocks includes criteria such as a market capitalization greater than $2 billion, high operating and cash flow margins, no significant revenue declines in the past five years, reasonable valuation, low-debt capital structure, and strong momentum [6] Performance Metrics - The average 12-month forward returns for selected stocks are nearly 15%, with a win rate of approximately 60% for selections returning positive [8]

adrian825/iStock via Getty Images Listen here or on the go via Apple Podcasts and Spotify JD Henning, who runs Value and Momentum Breakouts, shares why following market signals is so important (0:30). Trading gold stocks (7:45). Highlighting beaten down healthcare (10:00). ETFs over single stocks (15:50). Favorite market ETFs (24:00). Crypto and gold sectors (26:30). Transcript Rena Sherbill: Very happy to welcome back to Investing Experts, JD Henning, who runs the investing group on Seeking Alpha Va ...

Core Insights - Three stocks are highlighted with strong momentum characteristics and a buy rank as of October 7th: eGain Corporation, StoneCo Ltd., and Alignment Healthcare, Inc. [1] Company Summaries - **eGain Corporation (EGAN)**: - Provides an AI-powered knowledge hub to enhance customer experiences - Zacks Rank 1 with a 52.2% increase in current year earnings estimate over the last 60 days - Shares increased by 51.4% in the last three months, outperforming the S&P 500's 7.8% gain - Holds a Momentum Score of A [1][2] - **StoneCo Ltd. (STNE)**: - A fintech company offering software solutions - Zacks Rank 1 with an 8.7% increase in current year earnings estimate over the last 60 days - Shares gained 9.7% in the last three months, also outperforming the S&P 500's 7.8% gain - Holds a Momentum Score of A [2] - **Alignment Healthcare, Inc. (ALHC)**: - A healthcare platform focused on seniors - Zacks Rank 1 with a 14.3% increase in current year earnings estimate over the last 60 days - Shares increased by 24.8% in the last three months, surpassing the S&P 500's 7.8% gain - Holds a Momentum Score of A [3]